Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rilpivirine (R278474) is a diarylpyrimidine derivative and reverse transcriptase inhibitor with antiviral activity against HIV-1 that is used in the treatment of HIV infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 32.00 | |
5 mg | In stock | $ 50.00 | |
10 mg | In stock | $ 80.00 | |
25 mg | In stock | $ 148.00 | |
50 mg | In stock | $ 255.00 | |
100 mg | In stock | $ 378.00 | |
500 mg | In stock | $ 886.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 73.00 |
Description | Rilpivirine (R278474) is a diarylpyrimidine derivative and reverse transcriptase inhibitor with antiviral activity against HIV-1 that is used in the treatment of HIV infections. |
In vitro | Rilpivirine, dissolved in PEG 400 and administered via intravenous injection at dosages of 4 mg/kg in rats and 1.25 mg/kg in dogs, exhibits half-lives of 4.4 hours and 31 hours, respectively. |
In vivo | Rilpivirine demonstrates antiviral activity against both wild-type and selective point single and double HIV-1 mutants, with an effective concentration (EC50) ranging from 0.1 to 2 nM. |
Synonyms | TMC278, R278474, DB08864 |
Molecular Weight | 366.42 |
Formula | C22H18N6 |
CAS No. | 500287-72-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 68 mg/mL (185.6 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Rilpivirine 500287-72-9 Microbiology/Virology Proteases/Proteasome Reverse Transcriptase HIV Protease antiviral diarylpyrimidine DAPY transcriptase TMC-278 reverse TMC278 DB-08864 Inhibitor R278474 Human immunodeficiency virus mutant DB 08864 NNRTI wild-type non-nucleoside R 278474 inhibit R-278474 TMC 278 resistance DB08864 HIV inhibitor